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Abstract
The National Institute for Health and Clinical Excellence (NICE) has recently released obesity guidelines for health risk. For
the first time in the UK, we estimate the utility of these guidelines by relating them to the established cardiovascular disease
(CVD) risk factors. Health Survey for England (HSE) 2006, a population-based cross-sectional study in England was used with
a sample size of 7225 men and women aged $35 years (age range: 35–97 years). The following CVD risk factor outcomes
were used: hypertension, diabetes, total and high density lipoprotein cholesterol, glycated haemoglobin, fibrinogen, C-
reactive protein and Framingham risk score. Four NICE categories of obesity were created based on body mass index (BMI)
and waist circumference (WC): no risk (up to normal BMI and low/high WC); increased risk (normal BMI & very high WC, or
obese & low WC); high risk (overweight & very high WC, or obese & high WC); and very high risk (obese I & very high WC or
obese II/III with any levels of WC. Men and women in the very high risk category had the highest odds ratios (OR) of having
unfavourable CVD risk factors compared to those in the no risk category. For example, the OR of having hypertension for
those in the very high risk category of the NICE obesity groupings was 2.57 (95% confidence interval 2.06 to 3.21) in men,
and 2.15 (1.75 to 2.64) in women. Moreover, a dose-response association between the adiposity groups and most of the
CVD risk factors was observed except total cholesterol in men and low HDL in women. Similar results were apparent when
the Framingham risk score was the outcome of interest. In conclusion, the current NICE definitions of obesity show utility for
a range of CVD risk factors and CVD risk in both men and women.
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Introduction
It is very well documented that the prevalence of overweight
and obesity in England and other high-income countries is
increasing at all ages: almost two-thirds of adults and a third of
children are so classified [1]. A series of studies have established
that obesity, typically indexed by body mass index (BMI), is
associated with premature mortality [2,3–6] elevated rates of
cardiovascular disease (CVD) risk [7,8], selected cancers [9,10,11],
disability [12–14] and, potentially, mental health problems [15–
17]. More recently, investigators have shown that waist circum-
ference (WC), an indicator of visceral fat, is also associated with
these health outcomes [18–25].
The National Institute for Health and Clinical Excellence
(NICE), a UK agency established in 1999 to assist health care
professionals in providing the best care based on current scientific
evidence, has endorsed using combined measures of general and
central adiposity in estimating the ‘health’ risks associated with
overweight and obesity [26]. However, the utility of these
recommendations has yet to be assessed. Accordingly, we
examined the predictive utility of these guidelines by relating
them to both CVD risk factors and a CVD risk score (the
Framingham index) using data from the Health Survey of
England, a large, representative sample of that country’s
population.
Methods
Data
The Health Survey for England (HSE) comprises a series of
annual surveys beginning in 1991. HSE is a repeat, cross-sectional
survey of independent samples designed to ascertain the preva-
lence of chronic diseases and their risk factors. Each year, a new,
representative sample of the population living in private house-
holds is selected. Herein, we utilised data from the 2006 survey as
this focused on cardiovascular disease risk factors. In the multi-
stage stratified sampling process, 13,680 addresses were randomly
identified. Up to 10 resident adults (aged 16 and over) at each
selected private household address were eligible for inclusion in the
survey. Interviews were held in 8,614 households with 14,142
adults aged 16 or over, of which 10,489 adults had a nurse visit
[27]. Full details of sampling method can be found elsewhere [27].
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Nurses obtained written consent from adults before taking blood
samples. This study is an analysis of previously collected data and
therefore ethical approval was not required for this study. Ethical
approval for this survey was obtained by the Health Survey for
England team from the London Multi-centre Research Ethics
Committee.
Assessment of Body Mass Index and Waist Circumference
At the interview stage, participants had their height measured
using a portable stadiometer. Measurement was taken without
shoes, with the participant stretching to their maximum height and
the head positioned in the Frankfort plane. Readings were taken to
the nearest millimetre. BMI was calculated using the usual
formulae: weight in kilograms divided by the square of height in
meters (kg/m2). The waist measurement was taken at the midpoint
between the lower rib and the upper margin of the iliac crest.
Measured using a tape with an insertion buckle at one end, two
readings were taken with the mean used in the present analysis.
Data from those who were considered by the interviewer to have
unreliable measurements, for example those who had excessive
clothing on, or women who were pregnant were excluded from the
analysis. We used the combined categories of BMI and WC as
defined by the NICE [26] which are based on three thresholds for
WC and five for BMI (table 1). For the current analyses, we used
the following four risk categories: no risk, increased risk, high risk and
very high risk.
CVD Risk Factors
A (non-fasting) sample of blood was taken by venepuncture from
study members aged 16 and over. The blood sample was analysed
for total and HDL cholesterol, glycated haemoglobin, fibrinogen,
and C-reactive protein. The following risk categories were used for
low HDL (,1.0 mmol/l in men, ,1.3 mmol/l in women),
hypertension (systolic blood pressure: $140 mmHg, diastolic
blood pressure: $90 mmHg), and total cholesterol ($5.0 mg/
dL). The Framingham risk score was calculated based on the
values of total cholesterol, HDL cholesterol, systolic and diastolic
blood pressure, diabetes, age, gender and smoking status [28].
Covariates
Participants were asked about their smoking behaviour during
the face to face interview and categorised as: never smokers, ex-
smokers and current smokers. The physical activity levels were
assessed by questions on occupational activity, walking, and sport
and recreation. Participants were asked about frequency, duration,
and intensity of the different types of activity which last for at least
15 minutes in the 4 weeks prior to interview. They were classified
as high (30 min or more of moderate intensity activity at least five
days a week), medium (30 min or more of moderate intensity
activity at least on 1 to 4 days a week), or low (lower levels of
activity) [27]. Alcohol consumption was reported in terms of units
of alcohol consumed on the heaviest drinking day in the past week;
one unit of alcohol corresponds to 10 ml by volume of pure
alcohol. Alcohol consumption was categorised into four groups:
none; low (up to and including four units); medium ($5 units but
#8 units) and high (.8 units). Respondents were assigned
occupational categories according to the National Statistics
Socioeconomic Classification (NS-SEC) [29] on the basis of their
most recent occupation. The following three categories of NS-SEC
were used: managerial and professional, intermediate, and routine
and manual occupations.
Statistical Analysis
In the present analyses we utilise data from men and women
aged 35 years or older. A total of 7225 individuals had data on
BMI and WC, while the analytical sample varied according to the
outcome under consideration (range: 4079 for complete data for
the Framingham risk score to 7225 for HDL). Data were weighted
for nonresponse to make the sample representative of the general
population; when analysing blood sample data, weights were
further corrected for nonresponse to the blood samples to reduce
bias and produce results that remained nationally representative.
In preliminary analyses, there was evidence that sex modified the
relation of NICE categories with BMI and WC (p,0.05) with the
biomarkers; as such, we present gender-specific results. Normality
of biomarkers was assessed with CRP log transformed; geometric
means are presented, and the natural log of the concentrations was
used in the regression models. The relationship between each of
the continuous outcomes and NICE was explored using ANOVA;
for dichotomous outcomes, chi-squared test was used. Unadjusted
and adjusted associations of NICE obesity categories with each of
the outcome variables were estimated by using simple and multiple
regression analysis. Logistic regression analyses were used when
the outcome was categorical (for example hypertension: yes or no);
linear regression when it was continuous (such as CRP). In
multivariable analyses we controlled for smoking status, physical
activity, alcohol consumption and occupational class. Analyses
were carried out using STATA (version 11.0 for Windows; Stata
Corporation, College Station, TX).
Table 1. NICE obesity categories based on combined BMI and WC.
BMI classification Waist circumference*
Low High Very high
Normal weight (up to 30 kg/m2) No increased risk No increased risk Increased risk
Overweight (25 to less than 30 kg/m2) No increased risk Increased risk High risk
Obesity I (30 to less than 35 kg/m2) Increased risk High risk Very high risk
Obesity II (35 to less than 40 kg/m2) Very high risk Very high risk Very high risk
Obesity III (40 kg/m2 or more) Very high risk Very high risk Very high risk
BMI: body mass index.
*Waist circumference is defined as: For men: low (,94 cm); high (94–102 cm); very high (.102 cm); For women: low (,80 cm); high (80–88 cm) and very high
(.88 cm).
doi:10.1371/journal.pone.0067764.t001
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Results
The characteristics of participants with respect to the NICE
categories of adiposity are shown separately in men (table 2) and
women (table 3). Participants in the low risk category were
younger and had more favourable levels of CVD risk factors than
those with high or very high risk category. For example, in the no
risk category compared to those in the very high risk category, the
levels of systolic blood pressure were 7 mm/Hg and 9 mm/Hg
lower in men and women, respectively. HDL levels were also
raised in the higher risk groups; the pattern of association for total
cholesterol was less clear. The concentration levels of fibrinogen
and CRP were significantly higher among those in very high
obesity risk category compared to those in no risk category. The
Framingham risk score was also highest among those with very
high risk category (p-value for trend,0.001). In general, there was
a graded linear relationship between risk categories of NICE and
CVD risk factors such that the beta coefficients or the odds ratios
of CVD risk factors increased in a step-wise manner with the
increase in the risk category.
Next, we present regression models for the association of the
NICE adiposity groupings with CVD risk factors. Unadjusted and
adjusted regression analyses of CVD risk factors in relation to the
adiposity categories of NICE are presented in Table 4. In both
men and women, for hypertension, the odds ratios were higher
across the three risk categories compared to no risk both. For
example, the odds ratios were 2.57 (95% confidence interval 2.06
to 3.21) of hypertension for those in very high risk category
compared to men in no risk category. A dose-response was also
observed across the three categories such that odds ratios of
hypertension increased with the increase in risk category (OR:
1.69, 1.95, 2.57 respectively for increased, high and very high risk
categories). The odds ratios remained unchanged when covariates
were added to the multivariable model. Likewise, HDL levels were
lowest in very high risk category among men both in unadjusted
and adjusted associations. The odds ratios were almost 6 times
higher (95% confidence interval 3.59 to 8.76) for diabetes for those
in very high risk category compared to no risk. Similarly, the levels
of fibrinogen and CRP increased with the increase in the risk
category and were highest for those in ‘very high risk category’.
The total cholesterol levels were not associated with risk categories
in men.
Similar results were obtained for women with the exception that
total cholesterol levels were associated with the risk categories
while HDL levels were not. Adjustments decrease the magnitude
of the association with diabetes in women but still the dose-
response along the risk categories was observed. When Framing-
ham risk score was used as an outcome, as expected, similar results
were obtained for men and women as were obtained for the risk
factors which comprise this risk algorithm. Again, a gradient across
the NICE adiposity categories was observed, with very high risk
category found to have the highest coefficient of score. This trend
was observed for men and women with much bigger beta
coefficients for women than men.
Discussion
Our main objective was to investigate the association of the
NICE obesity guidelines for cardiovascular disease risk factors,
and, in so doing, their predictive utility. Our results indicate that
using the NICE categories of BMI and WC are useful in
identifying people with increased risk of selected CVD risk factors.
Using the NICE categories of obesity risk, there were less
favourable levels of CVD risk factors in the ‘higher risk’ groups;
these effects were generally linear.
Table 2. Characteristics of participants (mean [sd]) by NICE obesity categories in the Health Survey of England (2006) – men.
n NICE adiposity categories
p-value for
trend
No risk Increased risk High risk Very high risk
Age (years) 3344 54.14 (14.13) 56.54 (13.26) 59.39 (13.33) 56.62 (12.53) ,0.001
BMI kg/m2 3344 24.15 (2.12) 27.23 (1.33) 28.67 (1.51) 33.51 (3.14) ,0.001
WC (cm) 3344 88.94 (5.56) 98.11 (2.44) 105.07 (4.10) 113.88 (8.37) ,0.001
Systolic blood pressure (mm/Hg) 2836 129.24 (15.30) 133.49 (16.27) 134.84 (15.72) 136.99 (16.95) ,0.001
Diastolic blood pressure (mm/Hg) 2836 73.51 (10.24) 75.62 (10.54) 76.10 (10.84) 78.29 (11.87) ,0.001
Total Cholesterol (mg/dL) 2526 5.44 (1.10) 5.63 (1.17) 5.52 (1.16) 5.49 (1.14) 0.50
HDL cholesterol (mg/dL) 2526 1.46 (0.37) 1.34 (0.32) 1.31 (0.32) 1.23 (0.29) ,0.001
HbA1C (mmol/l) 2499 5.49 (0.56) 5.61 (0.75) 5.80 (1.01) 5.88 (1.02) ,0.001
Framingham risk score* 1860 5.13 (3.10) 6.30 (2.93) 6.78 (2.94) 6.92 (2.66) ,0.001
Inflammatory markers
Fibrinogen (g/L) 1952 2.86 (0.71) 2.96 (0.70) 3.03 (0.69) 3.13 (0.78) ,0.001
CRP (mg/L) 2526 1.10 (3.25) 1.60 (3.00) 2.06 (2.92) 2.44 (2.71) ,0.001
Prevalence (%)
Hypertension 2836 22 32 35 40 ,0.001
Type 2 diabetes 2872 3 5 7 13 ,0.001
High cholesterol 2526 65 72 68 66 0.04
Low HDL levels 2526 4 7 11 13 ,0.001
BMI: body mass index; WC: waist circumference; HDL: high density lipoprotein; HbA1C: glycated haemoglobin; CRP: C-reactive protein.
*Lower scores denoted lower risk of CVD.
doi:10.1371/journal.pone.0067764.t002
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Comparison with Previous Studies
Our results essentially accord with other reports, mostly from
the North American population [19,30–32]. Using the National
Institute of Health (NIH) clinical guidelines in the US population,
Janssen et al [30] have shown that within the three BMI
categories, those with higher WC values were likely to have
unfavourable CVD outcomes compared with those with normal
WC values; again, these effects were stepwise. Likewise, Arden
et al. [31] have reported that the OR for the prediction of the
metabolic syndrome were elevated in overweight and obese
women but not men with a high WC compared with overweight
and obese women with a low WC, respectively. Zhu et al [19] by
using the National Health and Nutrition Examination Survey have
shown that combined measures of BMI and WC may provide a
higher overall test performance for CVD risk factors and may be
useful in some ethnic groups as a means of screening subjects for
further evaluation in the clinical setting. However, in a recent
study of 58 cohorts from 17 countries, Wormser et al. [33] argued
that BMI, waist circumference, and waist-to-hip ratio, whether
assessed singly or in combination, do not importantly improve
CVD risk prediction in people in developed countries when
additional information is available for systolic blood pressure,
history of diabetes, and lipids. The disagreement of these results
might be due to the difference from race, age, study design,
measurement method of WC, continuous or dichotomized
variable for WC or using different categories of WC than what
we have used in the current study.
Mechanisms and Policy Implications
It is generally recognised that the central deposition of fat
(abdominal or visceral obesity) is closely associated with chronic
diseases and is a key constituent of the metabolic syndrome, a
disorder characterised by increased risk of developing diabetes,
stroke and cardiovascular disease [34]. Combined measures of
BMI and WC can help identify more adults who might have
elevations in CVD risk factors. Thus, results from our study have
strengthened the fact that both BMI and WC are the screening
CVD risk tools in England. Furthermore, the National Institutes of
Health (NIH) [35] guidelines found that BMI gave a reasonable
approximation of adiposity in most people and that waist
circumference was the most practical measurement for assessing
abdominal fat. The NICE evidence-based guidelines on obesity
include details on prevention, identification, assessment and
management of overweight and obesity, with one aim being to
increase health professionals’ awareness of how to manage
overweight and obesity in primary care. Our analyses have shown
associations of overweight and obesity along with high or very high
waist circumference on various risk factors of CVD. These results
confirm the need for healthcare professionals to incorporate into
clinical decision-making the NICE obesity guidelines which take
into account both the waist circumference measurements and
BMI. Treatment of overweight and obesity should be implement-
ed through effective evidence-based weight management inter-
ventions such as those highlighted in the NICE guidelines,
alongside broader preventive strategies at the population level.
Strengths and Weaknesses of the Study
This study has several strengths. First, the findings were based
on a large scale national level survey in England and this particular
sample of HSE (2006) was especially designed to study cardiovas-
cular disease risk in the population. By using the NICE obesity
categories, we have validated the effectiveness of using the
combined categories of BMI and WC in identifying the CVD
risk factors. Additionally, we have shown that in the setting of
England, the NICE obesity categories work more effectively than
the combined categories of BMI and WC used in the US as
recommended by NIH [35]. There are a number of limitations to
Table 3. Characteristics of participants (mean [sd]) by NICE obesity categories in the Health Survey of England (2006) – women.
n NICE adiposity categories p-value for trend
No risk Increased risk High risk Very high risk
Age (years) 3881 52.89 (13.31) 55.92 (13.71) 59.25 (13.88) 56.83 (13.38) ,0.001
BMI kg/m2 3881 22.83 (2.08) 26.43 (1.67) 28.00 (1.47) 34.72 (4.11) ,0.001
WC (cm) 3881 76.69 (5.31) 85.39 (3.87) 93.59 (4.96) 104 17 (9.79) ,0.001
Systolic BP (mm/Hg) 3375 123.83 (18.68) 127.26 (18.68) 132.05 (20.47) 132.27 (18.25) ,0.001
Diastolic BP (mm/Hg) 3375 71.93 (10.22) 73.66 (10.27) 74.77 (10.66) 77.38 (10.93) ,0.001
Total Cholesterol (mg/dL) 2934 5.56 (1.06) 5.71 (1.11) 5.83 (1.24) 5.81 (1.19) ,0.001
HDL cholesterol (mg/dL) 2934 1.78 (0.42) 1.67 (0.36) 1.56 (0.35) 1.49 (0.32) ,0.001
HbA1C (mmol/l) 2906 5.43 (0.49) 5.48 (0.44) 5.65 (0.65) 5.80 (0.86) ,0.001
Framingham risk score* 2219 1.61 (4.17) 2.83 (4.16) 4.53 (4.32) 4.83 (4.23) ,0.001
Fibrinogen (g/L) 2337 2.91 (0.72) 3.08 (0.62) 3.16 (0.68) 3.39 (0.69) ,0.001
CRP{ (mg/L) 2931 0.97 (3.26) 1.51 (2.87) 1.94 (2.76) 3.56 (2.56) ,0.001
Prevalence %
Hypertension 3375 19 23 31 33 ,0.001
Type 2 diabetes 3354 2 2 6 9 ,0.001
High cholesterol 2934 70 74 76 76 0.009
Low HDL levels 2934 1.11 0.80 1.48 2.37 0.078
BMI: body mass index; WC: waist circumference; HDL: high density lipoprotein; HbA1C: glycated haemoglobin; CRP: C-reactive protein.
*Lower scores denoted lower risk of CVD.
{Geometric means are reported.
doi:10.1371/journal.pone.0067764.t003
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Table 4. Odds ratios or b coefficients (95% CI) for the relation of NICE obesity categories with CVD risk factors in the Health Survey
of England (2006).
Men Women
Model 1 Model 2 Model 1 Model 2
Hypertension Odds ratios Odds ratios
No risk 1 (ref) 1 1 1
Increased risk 1.69 (1.34 to 2.14) 1.67 (1.28 to 2.17) 1.31 (1.02 to 1.67) 1.20 (0.90 to 1.60)
High risk 1.95 (1.52 to 2.51) 1.73 (1.29 to 2.32) 2.00 (1.59 to 2.50) 1.79 (1.38 to 2.34)
Very high risk 2.57 (2.06 to 3.21) 2.54 (1.97 to 3.28) 2.15 (1.75 to 2.64) 2.18 (1.71 to 2.77)
P for trend ,0.001 ,0.001 ,0.001 ,0.001
Diabetes Odds ratios Odds ratios
No risk 1 (ref) 1 1 1
Increased risk 1.89 (1.11 to 3.21) 2.10 (1.06 to 4.17) 1.04 (0.47 to 2.27) 0.73 (0.24 to 2.25)
High risk 2.60 (1.53 to 4.43) 2.08 (1.00 to 4.32) 3.85 (2.25 to 6.59) 3.67 (1.89 to 7.10)
Very high risk 5.61 (3.59 to 8.76) 5.90 (3.28 to 10.64) 5.83 (3.61 to 9.42) 4.05 (2.18 to 7.55)
P for trend ,0.001 ,0.001 ,0.001 ,0.001
Raised total cholesterol Odds ratios Odds ratios
No risk 1 (ref) 1 1 1
Increased risk 1.51 (1.19 to 1.92) 1.58 (1.21 to 2.06) 1.31 (1.02 to 1.67) 1.25 (0.96 to 1.63)
High risk 1.34 (1.04 to 1.74) 1.63 (1.21 to 2.18) 1.39 (1.09 to 1.78) 1.60 (1.21 to 2.12)
Very high risk 1.18 (0.94 to 1.49) 1.28 (0.99 to 1.64) 1.36 (1.09 to 1.70) 1.50 (1.17 to 1.91)
P for trend 0.13 0.03 0.002 ,0.001
Low HDL Odds ratios Odds ratios
No risk 1 (ref) 1 1 1
Increased risk 0.69 (0.43 to 1.12) 0.55 (0.33 to 0.93) 1.39 (0.40 to 4.81) 1.23 (0.36 to 4.19)
High risk 0.40 (0.25 to 0.64) 0.36 (0.21 to 0.62) 0.77 (0.29 to 2.08) 0.69 (0.23 to 2.02)
Very high risk 0.33 (0.21 to 0.50) 0.26 (0.17 to 0.42) 0.49 (0.23 to 1.08) 0.72 (0.30 to 1.76)
P for trend ,0.001 ,0.001 0.07 0.39
HbA1C (mmol/l) b coefficients* b coefficients*
No risk 0 (ref) 0 0 0
Increased risk 0.13 (0.05 to 0.21) 0.13 (0.05 to 0.21) 0.05 (20.00 to 1.00) 0.01 (20.04 to 0.06)
High risk 0.32 (0.19 to 0.45) 0.26 (0.14 to 0.39) 0.23 (0.16 to 0.30) 0.15 (0.08 to 0.23)
Very high risk 0.40 (0.29 to 0.51) 0.38 (0.27 to 0.49) 0.39 (0.31 to 0.46) 0.31 (0.24 to 0.39)
P for trend ,0.001 ,0.001 ,0.001 ,0.001
Framingham risk score b coefficients* b coefficients*
No risk 0 (ref) 0 0 0
Increased risk 1.11 (0.73 to 1.49) 0.91 (0.64 to 1.19) 1.24 (0.71 to 1.76) 0.74 (0.34 to 1.14)
High risk 1.62 (1.20 to 2.05) 1.08 (0.75 to 1.41) 2.96 (2.43 to 3.49) 1.94 (1.52 to 2.36)
Very high risk 1.86 (1.52 to 2.21) 1.67 (1.40 to 1.94) 3.27 (2.80 to 3.75) 2.64 (2.25 to 3.03)
P for trend ,0.001 ,0.001 ,0.001 ,0.001
Fibrinogen (g/L) b coefficients* b coefficients*
No risk 0 (ref) 0 0 0
Increased risk 0.10 (0.01 to 0.19) 0.09 (0.01 to 0.18) 0.19 (0.10 to 0.27) 0.17 (0.08 to 0.25)
High risk 0.14 (0.04 to 0.24) 0.10 (0.01 to 0.20) 0.25 (0.16 to 0.33) 0.25 (0.16 to 0.33)
Very high risk 0.27 (0.18 to 0.37) 0.29 (0.19 to 0.39) 0.49 (0.41 to 0.56) 0.47 (0.39 to 0.55)
P for trend ,0.001 ,0.001 ,0.001 ,0.001
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this study which need to be considered It has been remained
unclear and not very much debated that whether there should be a
set of separate cut-offs for WC when used in combination with
BMI [36]. This aspect needs further investigation. Any future
research on this topic should address the associations of NICE
obesity categories with mortality. Also, we did not address the issue
of reverse causation, i.e. the possibility that CVD risk factors
caused adiposity either independently or through other factors
such as dietary intake and other life style factors. We did not have
the data on other CVD risk factors such as IL6, triglycerides and
low-density lipoprotein cholesterol. Finally, we were unable to do
analysis stratified by race or ethnicity as the sample was 95%
white.
Conclusions
This is the first study in England which has demonstrated the
effectiveness of the combined categories of BMI and WC in
relation to CVD risk factors. Additionally, this study has used three
cut-offs of WC instead of using a dichotomous WC allowing a
more fine grained analysis. Our study suggests that CVD health
risk is greater in overweight and obese for those who have high
and very high WC compared with people with normal WC values.
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